SV

Street Verdict

Analyst Scorecard

A record of what Axis Securities Analysis said publicly, with the source. Not advice.

Pending — not yet graded
“Recommends 'buy' on Fortis Healthcare, targeting ₹775, as the hospital sector shows strong growth trajectory backed by structural tailwinds. These include increased surgical volumes, improved payer mix, and rising demand for high-growth therapies, contributing to higher ARPOB and occupancy rates, with industry ARPOB expected to grow 6-7% annually.”

Axis Securities Analysis’s track record (trackable calls only): 155 graded calls · 95% CI 34–49%

Fortis HealthcareBullishCalled 05 Jun 2025
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Axis Securities Analysis’s full track record